Skip to search formSkip to main contentSkip to account menu

GSK1325756

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background: Danirixin (DNX) is a competitive, reversible CXCR2 chemokine receptor antagonist. CXCR2 antagonists inhibit… 
2014
2014
Danirixin (GSK1325756) is a small, high-affinity, selective and reversible CXCR2 antagonist in development for treatment of… 
2013
2013
Characterization of the biliary disposition of GSK1325756, using a non‐invasive bile sampling technique and spectrometric…